183 related articles for article (PubMed ID: 1624081)
1. Effects of secretin on bile production in two kinds of cholestatic models by choledocho-caval fistula and bile duct ligation in rats.
Fukumoto Y; Ando M; Yasunaga M; Okuda M; Okita K
Gastroenterol Jpn; 1992 Jun; 27(3):396-404. PubMed ID: 1624081
[TBL] [Abstract][Full Text] [Related]
2. The effect of secretin on bile flow and bile acid and bilirubin excretion following relief of prolonged bile duct obstruction in the rat.
Kountouras J; McKavanagh S; Burmicky M; Billing BH
J Hepatol; 1987 Apr; 4(2):198-205. PubMed ID: 3584928
[TBL] [Abstract][Full Text] [Related]
3. Secretin prevents taurocholate-induced intrahepatic cholestasis in the rat.
Fukumoto Y; Ando M; Yasunaga M; Okuda M; Okita K
J Hepatol; 1994 Jun; 20(6):750-4. PubMed ID: 7930475
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.
Barone M; Maiorano E; Ladisa R; Pece A; Berloco P; Strazzabosco M; Caruso ML; Valentini AM; Ierardi E; Di Leo A; Francavilla A
Virchows Arch; 2004 Jun; 444(6):554-60. PubMed ID: 15071740
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences between models of extrahepatic biliary obstruction and complete biliary retention without obstruction in the rat.
Hardison WG; Weiner RG; Hatoff DE; Miyai K
Hepatology; 1983; 3(3):383-90. PubMed ID: 6840684
[TBL] [Abstract][Full Text] [Related]
6. Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver.
Hirata K; Nathanson MH
Gastroenterology; 2001 Aug; 121(2):396-406. PubMed ID: 11487549
[TBL] [Abstract][Full Text] [Related]
7. The effect of prostanoids on hepatic bile flow in dogs with normal liver and bile duct cell hyperplasia.
Solomon H; Contis J; Li AP; Kaminski DL
Prostaglandins Leukot Essent Fatty Acids; 1996 Apr; 54(4):265-71. PubMed ID: 8804123
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis.
Omland E; Mathisen O
Scand J Gastroenterol; 1991 May; 26(5):513-22. PubMed ID: 1871544
[TBL] [Abstract][Full Text] [Related]
9. Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.
Mancinelli R; Onori P; Gaudio E; Franchitto A; Carpino G; Ueno Y; Alvaro D; Annarale LP; Demorrow S; Francis H
Exp Biol Med (Maywood); 2009 Apr; 234(4):462-74. PubMed ID: 19234059
[TBL] [Abstract][Full Text] [Related]
10. Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats.
Baiocchi L; Alpini G; Glaser S; Angelico M; Alvaro D; Francis H; Marzioni M; Phinizy JL; Barbaro B; LeSage G
J Hepatol; 2003 Feb; 38(2):136-47. PubMed ID: 12547401
[TBL] [Abstract][Full Text] [Related]
11. [Choleretic effects of taurine on experimentally-induced intrahepatic cholestasis].
Sakagami C; Kioka K; Mizoguchi Y; Kida T; Hasegawa I; Ichikawa Y; Tsutsui H; Kobayashi K; Morisawa S
Nihon Shokakibyo Gakkai Zasshi; 1992 Apr; 89(4):1179-84. PubMed ID: 1593775
[TBL] [Abstract][Full Text] [Related]
12. Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats.
Alpini G; Glaser S; Baiocchi L; Francis H; Xia X; Lesage G
Hepatology; 2005 May; 41(5):1037-45. PubMed ID: 15834929
[TBL] [Abstract][Full Text] [Related]
13. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats.
Alpini G; Glaser S; Alvaro D; Ueno Y; Marzioni M; Francis H; Baiocchi L; Stati T; Barbaro B; Phinizy JL; Mauldin J; Lesage G
Gastroenterology; 2002 Oct; 123(4):1226-37. PubMed ID: 12360484
[TBL] [Abstract][Full Text] [Related]
14. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
[TBL] [Abstract][Full Text] [Related]
15. [The descending pathophysiology model of cholestatic liver disease].
Cai XB; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):321-324. PubMed ID: 31177654
[TBL] [Abstract][Full Text] [Related]
16. Assessment of biliary bicarbonate secretion in humans by positron emission tomography.
Prieto J; García N; Martí-Climent JM; Peñuelas I; Richter JA; Medina JF
Gastroenterology; 1999 Jul; 117(1):167-72. PubMed ID: 10381924
[TBL] [Abstract][Full Text] [Related]
17. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules.
Alpini G; Lenzi R; Sarkozi L; Tavoloni N
J Clin Invest; 1988 Feb; 81(2):569-78. PubMed ID: 2448343
[TBL] [Abstract][Full Text] [Related]
18. Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine.
Ballatori N; Truong AT
Mol Pharmacol; 1990 Jul; 38(1):64-71. PubMed ID: 2115113
[TBL] [Abstract][Full Text] [Related]
19. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes.
Buscher HP; Miltenberger C; MacNelly S; Gerok W
J Hepatol; 1989 Mar; 8(2):181-91. PubMed ID: 2715621
[TBL] [Abstract][Full Text] [Related]
20. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]